✦ LIBER ✦

A Markov Model of the Cost Effectiveness of Olanzapine Treatment for Agitation and Psychosis in Alzheimer’s Disease

✍ Scribed by Stephanie Kirbach, Kit Simpson, Paul J. Nietert, Jacobo Mintzer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of the agitation of late-life

✍ C Salzman 📂 Article 📅 2001 🏛 Elsevier Science 🌐 French ⚖ 62 KB

The cost-effectiveness of donepezil ther

✍ Linus Jönsson; Peter Lindgren; Anders Wimo; Bengt Jönsson; Bengt Winblad 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 685 KB

PMH35 COST-EFFECTIVENESS OF MEMANTINE IN

✍ Rive, B; Grishchenko, M; Guilhaume, C; Katona, C; Lamure, M; Livingston, G; Toum 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Cost Effectiveness of Cholinesterase Inh

✍ Dr Anders Wimo 📂 Article 📅 2004 🏛 Springer International Publishing AG 🌐 English ⚖ 162 KB

Long-term cost-effectiveness of donepezi

✍ Stefan J. Teipel; Michael Ewers; Veronika Reisig; Bernd Schweikert; Harald Hampe 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 252 KB

Olanzapine for the Treatment of Psychosi

✍ Laura Marsh; Constantine Lyketsos; Stephen G. Reich 📂 Article 📅 2001 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 154 KB